Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Eppendorf Launches New Mastercycler nexus X2

Published: Friday, March 14, 2014
Last Updated: Thursday, March 13, 2014
Bookmark and Share
Provides solution for simultaneous PCR runs.

Eppendorf has launched the latest offering in its range of molecular biology instruments. The new Mastercycler nexus X2 is ideal for researchers looking to carry out two runs of PCR simultaneously, without any compromise on the number of samples.

The instrument comprises of two asymmetric blocks, consisting of 64 and 32 wells, which can be programmed and run completely independently, enabling two separate PCR protocols to be run in parallel.

With reduced noise emission (< 40 dB), low power consumption and a small, well-designed footprint, the Mastercycler nexus X2 is perfectly suited for use in busy academic laboratories, or any institution with multiple users or large research groups.

In comparison to other dual block cyclers, it provides an elegant solution for users wishing to run procedures using a large number of samples, without taking up a large amount of bench space.

“Many of our customers have expressed a need for a multi-block cycler that can accommodate more than 48 samples in a single block,” said Dr. Kay Körner, Global Senior Product Manager of PCR at Eppendorf.

Dr. Körner continued, “In response to this, we developed the Mastercycler nexus X2’s asymmetric block. In nature, functional asymmetry is a well known phenomenon - we are confident it will also work in a lab.”

As the latest addition to the popular Mastercycler range, the Mastercycler nexus X2 continues Eppendorf’s legacy of exceptional design and ease of use combined with efficiency and accuracy.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thomas Bachmann is New Chief Executive Officer of the Eppendorf Group
Thomas Bachmann became Chief Executive Officer of the Eppendorf Group on August 1, 2015.
Tuesday, August 04, 2015
Scientific News
Five New Breast Cancer Genes Found
Discovery of mutations paves the way for personalised treatment of breast cancer.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Magnetic Nanoparticles May Reveal Early Traces Of Cancer
Rice University students’ computer program aids MD Anderson diagnostic initiative .
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
World-First Blood Test For Parkinson's
La Trobe University researchers have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease.
Parsortix Demonstrates Benefits Over Marker-Based Systems
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumour cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis.
Hepatitis C Virus Testing Guidelines Miss Too Many Cases
Urban emergency departments a good place to enact universal screening for adults.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!